Darui Bio

大睿生物

Darui Bio

Biotech/Healthcare

Daruibo, founded in 2021, is building a proprietary platform to develop innovative and disruptive nucleic acid therapeutics with high specificity, stability, and durability. Using its proprietary delivery platform, the company develops nucleic acid drugs through modular and programmable approaches…

Latest round: Pre Series B (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-03-01